APA-viite

Lee, J., Annunziata, C. M., Hays, J. L., Cao, L., Choyke, P., Yu, M., . . . Kohn, E. C. (2020). Phase II trial of bevacizumab and sorafenib in recurrent ovarian cancer patients with or without prior-bevacizumab treatment. Gynecol Oncol.

Chicago-tyylinen lähdeviittaus

Lee, Jung-Min, et al. "Phase II Trial of Bevacizumab and Sorafenib in Recurrent Ovarian Cancer Patients With or Without Prior-bevacizumab Treatment." Gynecol Oncol 2020.

MLA-viite

Lee, Jung-Min, et al. "Phase II Trial of Bevacizumab and Sorafenib in Recurrent Ovarian Cancer Patients With or Without Prior-bevacizumab Treatment." Gynecol Oncol 2020.

Varoitus: Nämä viitteet eivät aina ole täysin luotettavia.